Title

RNA Therapeutics: Informational drugs as a pandemic response tool

Date

2020-04-30

Document Type

Presentation

Streaming Media

Description

This presentation, hosted by the Community Engagement and Research Section, University of Massachusetts Medical School Center for Clinical and Translational Science, describes the development of siRNA-based approaches for modulation of COVID-19 in the lung in a three-month time frame.

This talk was the second in the COVID-19 Research Community Forum webinar series, a collaboration of the four federally-funded Clinical and Translational Science Awardees (CTSA) in Massachusetts, that provided an opportunity for community members, institutions and other organizations to be part of the discussions surrounding the COVID-19 pandemic. The MA CTSAs, consisting of the UMass Center for Clinical and Translational Science, Tufts Clinical and Translational Science Institute, Harvard Catalyst, and Boston University Clinical and Translational Science Institute, offered community forums with researchers to hear about COVID-19 research happening here in Massachusetts.

Keywords

2019-nCoV, COVID-19, SARS-2-CoV, SARS-2, 2019 novel coronavirus disease, clinical and translational science, CTSA, Massachusetts, research

DOI

10.13028/v3re-kf81

Rights and Permissions

Copyright 2020 The Author(s)

Share

COinS
 
Apr 30th, 4:00 PM

RNA Therapeutics: Informational drugs as a pandemic response tool

This presentation, hosted by the Community Engagement and Research Section, University of Massachusetts Medical School Center for Clinical and Translational Science, describes the development of siRNA-based approaches for modulation of COVID-19 in the lung in a three-month time frame.

This talk was the second in the COVID-19 Research Community Forum webinar series, a collaboration of the four federally-funded Clinical and Translational Science Awardees (CTSA) in Massachusetts, that provided an opportunity for community members, institutions and other organizations to be part of the discussions surrounding the COVID-19 pandemic. The MA CTSAs, consisting of the UMass Center for Clinical and Translational Science, Tufts Clinical and Translational Science Institute, Harvard Catalyst, and Boston University Clinical and Translational Science Institute, offered community forums with researchers to hear about COVID-19 research happening here in Massachusetts.